Cargando…

Suppression of human epidermal growth factor receptor 2 via interference increases the chemosensitivity of ovarian carcinoma

The function of human epidermal growth factor receptor 2 (HER2) in the chemosensitivity of ovarian carcinoma has not been fully investigated, therefore, the present study aimed to analyze the potential role of HER2 in ovarian carcinoma chemosensitivity in further detail. SKOV3 cells were transfected...

Descripción completa

Detalles Bibliográficos
Autores principales:	SONG, XIAOPING, SUN, KAILV, HU, JIANMING, ZHOU, JIANGHU
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840778/ https://www.ncbi.nlm.nih.gov/pubmed/27123058 http://dx.doi.org/10.3892/ol.2016.4341

Ejemplares similares

Expression and clinical significance of NCOA5 in epithelial ovarian cancer
por: Song, Xiaoping, et al.
Publicado: (2023)

Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth
por: Khurana, Ashwani, et al.
Publicado: (2015)

miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin
por: Tian, Hang, et al.
Publicado: (2022)

Puerarin increases the chemosensitivity of hepatocellular carcinoma cells
por: Wu, Zhen, et al.
Publicado: (2017)

Dexamethasone affects cell growth/apoptosis/chemosensitivity of colon cancer via glucocorticoid receptor α/NF-κB
por: He, Jianming, et al.
Publicado: (2017)

Epidermal growth factor receptors (EGFR) in human ovarian cancer.
por: Owens, O. J., et al.
Publicado: (1991)

The status of epidermal growth factor receptor in borderline ovarian tumours
por: Showeil, Rania, et al.
Publicado: (2016)

Chlorogenic Acid: The Conceivable Chemosensitizer Leading to Cancer Growth Suppression
por: Lukitasari, Mifetika, et al.
Publicado: (2018)

Effect of BRCA1 on epidermal growth factor receptor in ovarian cancer
por: Li, Da, et al.
Publicado: (2013)

Inhibition LC3B can increase chemosensitivity of ovarian cancer cells
por: Tang, Jing, et al.
Publicado: (2019)

TIMP-3 Increases the Chemosensitivity of Laryngeal Carcinoma to Cisplatin via Facilitating Mitochondria-Dependent Apoptosis
por: Shen, Xiaohui, et al.
Publicado: (2018)

Role of Epidermal Growth Factor Receptor-Specific CAR-T Cells in the Suppression of Esophageal Squamous Cell Carcinoma
por: Cheng, Chen, et al.
Publicado: (2022)

ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma
por: Chen, Weiqian, et al.
Publicado: (2020)

RNA Interference-Mediated Knockdown of Astrocyte Elevated Gene-1 Inhibits Growth, Induces Apoptosis, and Increases the Chemosensitivity to 5-Fluorouracil in Renal Cancer Caki-1 Cells
por: Wang, Peng, et al.
Publicado: (2014)

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer
por: Bonello, Maria, et al.
Publicado: (2018)

Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signaling
por: Wang, Yanqiu, et al.
Publicado: (2018)

Tumor metabolism regulating chemosensitivity in ovarian cancer
por: Han, Chae Young, et al.
Publicado: (2018)

DEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity
por: Cui, Danrui, et al.
Publicado: (2020)

Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance
por: Ranjbar, Reza, et al.
Publicado: (2015)

Association of Cortactin, Fascin-1 and Epidermal Growth Factor Receptor (EGFR) Expression in Ovarian Carcinomas: Correlation with Clinicopathological Parameters
por: Lin, Chih-kung, et al.
Publicado: (2008)

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
por: Filipe, M. I., et al.
Publicado: (1995)

Novel parameter for cancer chemosensitivity to fibroblast growth factor receptor inhibitors
por: Kitano, Shoichi, et al.
Publicado: (2022)

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.
por: Henzen-Logmans, S. C., et al.
Publicado: (1992)

Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
por: Granados, Michaela L., et al.
Publicado: (2015)

Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
por: Yu, Yi, et al.
Publicado: (2014)

VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
por: YAO, RUCHENG, et al.
Publicado: (2014)

Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway
por: Jiang, Shaoyan, et al.
Publicado: (2019)

Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy
por: Sun, Wei, et al.
Publicado: (2017)

METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
por: Li, Ruyi, et al.
Publicado: (2021)

Pescadillo ribosomal biogenesis factor 1 reduction suppresses tumour growth and renders chemosensitivity of head and neck squamous cell carcinoma
por: Li, Dapeng, et al.
Publicado: (2022)

Effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells
por: Li, Xueqing, et al.
Publicado: (2018)

Immunohistochemical detection of epidermal growth factor receptors on human colonic carcinomas.
por: Steele, R. J., et al.
Publicado: (1990)

Epidermal growth factor receptor expression in canine transitional cell carcinoma
por: HANAZONO, Kiwamu, et al.
Publicado: (2014)

The immunoexpression of epidermal growth factor receptor in cutaneous squamous cell carcinoma
por: Nichita, Mirela Marcela, et al.
Publicado: (2021)

Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma
por: Amirabadi, Amir, et al.
Publicado: (2021)

BRCA1 Expression is an Important Biomarker for Chemosensitivity: Suppression of BRCA1 Increases the Apoptosis via Up-regulation of p53 and p21 During Cisplatin Treatment in Ovarian Cancer Cells
por: Horiuchi, Akiko, et al.
Publicado: (2007)

A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma
por: Matsumura, Sosuke, et al.
Publicado: (2023)

Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma
por: An, Jeongshin, et al.
Publicado: (2019)

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.
por: Bartlett, J. M., et al.
Publicado: (1996)

Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
por: Siwak, Doris R., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_n44ih8onihncdp4qeski2npqha